Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults

Ge Li, Jane B. Shofer, Eric C. Petrie, Chang En Yu, Charles W. Wilkinson, Dianne P. Figlewicz, Andrew Shutes-David, Jing Zhang, Thomas J. Montine, Murray A. Raskind, Joseph F. Quinn, Douglas R. Galasko, Elaine R. Peskind

Research output: Contribution to journalArticle

12 Scopus citations

Abstract

Background: This study sought to evaluate gender and APOE genotype-related differences in the concentrations of cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease (AD) and cerebrovascular injury across the life span of cognitively normal adults. Methods: CSF amyloid beta1-42 (Aβ42), phospho-Tau-181 (p-Tau181), and total tau were measured in 331 participants who were between the ages of 21 and 100. CSF E-selectin and vascular cell adhesion protein 1 (VCAM1) were measured in 249 participants who were between the ages of 50 and 100. Results: CSF total tau and p-Tau181 increased with age over the adult life span (p < 0.01) with no gender differences in those increases. CSF Aβ42 concentration varied according to age, gender, and APOE genotype (interaction of age × gender × ϵ4, p = 0.047). CSF VCAM1, but not E-selectin, increased with age (p < 0.01), but both were elevated in men compared to women (p < 0.01). Conclusions: Female APOE-ϵ4 carriers appear at higher risk for AD after age 50. In contrast, men may experience a relatively higher rate of cerebrovascular injury in middle and early old age.

Original languageEnglish (US)
Article number48
JournalAlzheimer's Research and Therapy
Volume9
Issue number1
DOIs
StatePublished - Jul 3 2017

Keywords

  • APOE genotype
  • Age
  • Alzheimer's disease
  • Biomarkers
  • Cerebrospinal fluid
  • Cerebrovascular disease
  • Gender

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology
  • Cognitive Neuroscience

Fingerprint Dive into the research topics of 'Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults'. Together they form a unique fingerprint.

  • Cite this

    Li, G., Shofer, J. B., Petrie, E. C., Yu, C. E., Wilkinson, C. W., Figlewicz, D. P., Shutes-David, A., Zhang, J., Montine, T. J., Raskind, M. A., Quinn, J. F., Galasko, D. R., & Peskind, E. R. (2017). Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults. Alzheimer's Research and Therapy, 9(1), [48]. https://doi.org/10.1186/s13195-017-0271-9